(Q33806753)

29 July 2017

1 reference

title

Choice of immunosuppressive drugs and individualization of immunosuppressive therapy for kidney transplant patients (English)

1 reference

29 July 2017

Danovitch GM

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Transplantation Proceedings

29 July 2017

published in

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

8A

1 reference

29 July 2017

page(s)

2S-6S

1 reference

Fifth report of The Human Kidney Transplant Registry.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Steroid withdrawal from cyclosporine-based regimens: con--a flawed strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Long-term results of pancreas transplantation under tacrolius immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900840-4

7 January 2021

10.1016/S0041-1345(99)00840-4

Identifiers

DOI

1 reference

29 July 2017

1 reference